QTTB - Latest News
Q32 Bio Inc. (QTTB), operates in Healthcare / Biotechnology, trades on NASDAQ.
Market capitalization stands near $164.2M. Trailing twelve-month P/E ratio is 5.45. Beta to the broader market is -1.27.
The article list below shows the most recent QTTB headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent QTTB Headlines
Q32 Bio: "Buy" On Bempikibart Advancement And Mid-2026 Data Catalysts
seekingalpha.com - May 28, 2026
I initiate Q32 Bio (QTTB) at 'Buy' due to advancing bempikibart for Alopecia Areata and strong upcoming catalysts. Company expects mid-2026 data from
Q32 Bio Announces $55 Million Private Placement Financing
prnewswire.com - May 27, 2026
WALTHAM, Mass. , May 27, 2026 /PRNewswire/ -- Q32 Bio Inc.
Wall Street Analysts Think Q32 Bio (QTTB) Could Surge 145.69%: Read This Before Placing a Bet
zacks.com - May 26, 2026
The average of price targets set by Wall Street analysts indicates a potential upside of 145. 7% in Q32 Bio (QTTB).
Wall Street Analysts Believe Q32 Bio (QTTB) Could Rally 163.42%: Here's is How to Trade
zacks.com - May 8, 2026
The consensus price target hints at a 163. 4% upside potential for Q32 Bio (QTTB).
Q32 Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update
prnewswire.com - May 5, 2026
-- Bempikibart 36-week topline data readout from Part B of SIGNAL-AA Phase 2a clinical trial on-track for mid-2026 -- -- First patient dosed in SIGNAL
How News Affects QTTB Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track QTTB's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked QTTB news questions
- What is the latest QTTB news headline?
- The most recent QTTB headline (May 28, 2026) is "Q32 Bio: "Buy" On Bempikibart Advancement And Mid-2026 Data Catalysts". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the QTTB news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What QTTB news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual QTTB options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.